Discover and read the best of Twitter Threads about #CoVaxine
Most recents (3)
देशातील #COVID19 परिस्थिती संदर्भात केंद्रीय आरोग्य मंत्रालयाची पत्रकापरिषद.
🕓 वेळ- 4 वाजता.
प्रसारणः
#Unite2FightCorona
🕓 वेळ- 4 वाजता.
प्रसारणः
#Unite2FightCorona
#Unite2FightCorona
दैनंदिन रुग्णसंख्येत सातत्याने घट
2 ऱ्या लाटेत नोंदवलेली सर्वोच्च रुग्णसंख्या-4,14,188
गेल्या 24 तासांत नोंदवलेली रुग्णसंख्या- 29,689
रुग्णसंख्या कमी होत असली तरी काही राज्यांमध्ये रुग्णसंख्येत सातत्य आहे, ही चिंतेची बाब आहे.
दैनंदिन रुग्णसंख्येत सातत्याने घट
2 ऱ्या लाटेत नोंदवलेली सर्वोच्च रुग्णसंख्या-4,14,188
गेल्या 24 तासांत नोंदवलेली रुग्णसंख्या- 29,689
रुग्णसंख्या कमी होत असली तरी काही राज्यांमध्ये रुग्णसंख्येत सातत्य आहे, ही चिंतेची बाब आहे.
#Unite2FightCorona
महाराष्ट्रातील सोलापूर आणि बीड जिल्ह्यात दैनंदिन रुग्णसंख्येत वाढ कायम.
यासंदर्भात राज्यांशी बोलणी सुरु आहे. राज्यांनी प्रतिबंधात्मक धोरणाची अंमलबजावणी, कोविड अनुरुप वर्तनाचे पालन करण्यासाठी उपाययोजना करणे गरजेचे.
@Info_Solapur @InfoBeed
महाराष्ट्रातील सोलापूर आणि बीड जिल्ह्यात दैनंदिन रुग्णसंख्येत वाढ कायम.
यासंदर्भात राज्यांशी बोलणी सुरु आहे. राज्यांनी प्रतिबंधात्मक धोरणाची अंमलबजावणी, कोविड अनुरुप वर्तनाचे पालन करण्यासाठी उपाययोजना करणे गरजेचे.
@Info_Solapur @InfoBeed
The #CovidVaccine is a $50 Billion opportunity
(Assume 5 Billion people taking vaccines 2 times every year, at $5)
And @BharatBiotech is very well positioned to capture a 10% market share with 1 Billion capacity. So such attacks will only increase.
(Assume 5 Billion people taking vaccines 2 times every year, at $5)
And @BharatBiotech is very well positioned to capture a 10% market share with 1 Billion capacity. So such attacks will only increase.
The Big Pharma Cartel was confident of securing a monopoly on this lucrative opportunity
Pfizer alone has forecasted > $25 Billion revenue from #vaccines this year after selling vaccines worth more than $3.5 Billion in the first quarter.
pharmaceutical-technology.com/features/pfize…
Pfizer alone has forecasted > $25 Billion revenue from #vaccines this year after selling vaccines worth more than $3.5 Billion in the first quarter.
pharmaceutical-technology.com/features/pfize…
At most, they expected some competition from China. But India? India has been seen as a back office, a mass producer of commodities, not as an innovator or a place that can research, develop vaccines.
That's where @BharatBiotech #covaxine has surprised them.
#IndiaFightsCorona
That's where @BharatBiotech #covaxine has surprised them.
#IndiaFightsCorona
3rd Phase #Covaxine trial taking place in Bhopal hasviolated every rule in d book
Poor & vulnerable residents of gas
affected communities r herded by d People's 🏥 with a promise of Rs750. No copy of informed consent is being given 2 d participants @CDSCO_INDIA_INF
Poor & vulnerable residents of gas
affected communities r herded by d People's 🏥 with a promise of Rs750. No copy of informed consent is being given 2 d participants @CDSCO_INDIA_INF
Most of these participants are from 3-4 communities situated near People 🏥. Most r told that they r being given d vaccine to stop COVID-19 and not that they r part of a 3rd Phase trial. None of them have recvd reports of their blood & PCR samples. @CDSCO_INDIA_INF
When a participant experiences an adverse event they call up d hospital who asks them to come in and then they r prescribed medicines & investigations where the participant is expected to foot the bill. Things cannot get any worse than this. @CDSCO_INDIA_INF
